Schedule 13G ownership disclosure

Akari Therapeutics Plc

Security class unavailable · CUSIP: 00972G108

Event date: 2018-06-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.9400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-224465
Form type
SC 13G
Filer
Akari Therapeutics Plc
CIK
CIK 1541157
Filed
Aug 19, 2019
Reporting period
Jun 19, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub